Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort

Cerebrovascular Diseases

Volumn 33, Issue 2, 2012, Pages 190-197

  Flynn, Robert W V ^a   MacDonald, Thomas M ^a   Murray, Gordon D ^b   MacWalter, Ronald S ^a   Doney, Alexander S F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Antiplatelet regimens; Cardiovascular diseases; Cerebral infarction; Platelet aggregation inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ASPIRIN; CEREBRAL INFARCTION; COHORT STUDIES; DIPYRIDAMOLE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MEDICAL RECORD LINKAGE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ADHERENCE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; SURVIVAL ANALYSIS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855878750     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000331933     Document Type: Article

References (19)

1. Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
2. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13. (Pubitemid 26402780)
3. Algra A: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-1673.
4. Mayor S: NICE guidance to prevent strokes and heart attacks lacks evidence. BMJ 2005; 330: 1286.
5. The PRoFESS Study Group: Aspirin and extended- release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359: 1238-1251.
6. Wei L, Parkinson J, MacDonald TM: The Tayside medicines monitoring unit (MEMO); in Strom BL (ed): Pharmacoepidemiology. Chichester, Wiley, 2005, pp xvii, 889.
7. Flynn RW, MacDonald TM, Murray GD, Ferguson C, Shah K, Doney AS: The Tayside Stroke Cohort: exploiting advanced regional medical informatics to create a region-wide database for studying the pharmacoepidemiology of stroke. Pharmacoepidemiol Drug Saf 2010; 19: 737-744.
8. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS: Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010; 41: 2606-2611.
9. Flynn RW, Macdonald TM, Schembri N, Murray GD, Doney AS: Automated data capture from free-text radiology reports to enhance accuracy of hospital inpatient stroke codes. Pharmacoepidemiol Drug Saf 2010; 19: 843-847.
10. Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006; 40: 1280-1288. (Pubitemid 44204957)
11. Wettermark B, Persson A, von Euler M: Secondary prevention in a large stroke population: a study of patients' purchase of recommended drugs. Stroke 2008; 39: 2880-2885.
12. Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G: Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34: 1010-1014. (Pubitemid 36402980)
13. Volpato S, Maraldi C, Ble A, Ranzini M, Rita Atti A, Dominguez LJ, Barbagallo M, Fellin R, Zuliani G: Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study. Stroke 2004; 35: 913-917. (Pubitemid 38419802)
14. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC, German Stroke Data B: Adherence to secondary stroke prevention strategies - results from the German Stroke Data Bank. Cerebrovasc Dis 2003; 15: 282-288. (Pubitemid 36438733)
15. National Institute for Clinical Excellence: Technology Appraisal 90. Clopidogrel and Modified Release Dipyridamole in the Prevention of Occlusive Vascular Events. London, NICE, 2005.
16. Lummis HL, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ: Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol 2008; 8: 25.
17. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke H-C: Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 2001; 32: 1884-1889. (Pubitemid 32772225)
18. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA: A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 2006; 333: 15.
19. Wei L, Fahey T, MacDonald TM: Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. Br J Clin Pharmacol 2008; 66: 110-116. (Pubitemid 351822170)